Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10391175 BET bromodomain inhibitors and therapeutic methods using the same

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Yujun Zhao0

Shaomeng Wang0

Xiaoqin Li0

Xu Ran0

Arul Chinnaiyan0

Bing Zhou0

Chao-Yie Yang0

Donna McEachern0

...

Date of Patent

August 27, 2019

Patent Application Number

15619671

Date Filed

June 12, 2017

Patent Citations Received

US Patent 11028058 Heterocyclic compounds as adenosine antagonists

US Patent 11584756 Heterocyclic compounds as BET inhibitors

0

US Patent 11306071 Heterocyclic compounds as adenosine antagonists

US Patent 11254670 1,8-naphthyridinone compounds and uses thereof

US Patent 10793561 1,8-naphthyridinone compounds and uses thereof

0

Patent Primary Examiner

Andrew D. Kosar

Patent abstract

Inhibitors of BET bromodomains and compositions containing the same are disclosed. Methods of using the BET bromodomain inhibitors in the treatment of diseases and conditions wherein inhibition of BET bromodomain provides a benefit, like cancers, also are disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10391175 BET bromodomain inhibitors and therapeutic methods using the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool